Usana Health Sciences Inc SEC filings USNA
Usana Health Sciences Inc has 1,001 filings in SEC EDGAR's recent list, going back to Nov 13, 2017. Its latest annual report, Form ARS, was filed on Apr 7, 2026 for the period ended Jan 3, 2026. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jul 4, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on January 3.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 7, 2026 | Jan 3, 2026 |
| DEFA14A | Additional proxy material | May 1, 2025 | — |
| DEFA14A | Additional proxy material | Apr 16, 2025 | — |
| DEFA14A | Additional proxy material | Apr 9, 2025 | — |
| DEF 14A | Proxy statement | Apr 4, 2025 | Dec 28, 2024 |
| DEFA14A | Additional proxy material | Mar 27, 2024 | — |
| DEF 14A | Proxy statement | Mar 22, 2024 | Dec 30, 2023 |
| DEFA14A | Additional proxy material | Apr 14, 2023 | — |
| DEFA14A | Additional proxy material | Mar 31, 2023 | — |
| DEF 14A | Proxy statement | Mar 31, 2023 | — |
| DEFA14A | Additional proxy material | Mar 30, 2022 | — |
| DEF 14A | Proxy statement | Mar 30, 2022 | May 9, 2022 |
| DEFA14A | Additional proxy material | Mar 30, 2021 | — |
| DEF 14A | Proxy statement | Mar 30, 2021 | May 10, 2021 |
| DEFA14A | Additional proxy material | Mar 20, 2020 | — |
| DEF 14A | Proxy statement | Mar 20, 2020 | May 1, 2020 |
| DEFA14A | Additional proxy material | Mar 22, 2019 | — |
| DEF 14A | Proxy statement | Mar 22, 2019 | May 1, 2019 |
| DEFA14A | Additional proxy material | Mar 23, 2018 | — |
| DEF 14A | Proxy statement | Mar 23, 2018 | May 2, 2018 |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- USNA (NYSE)
- Fiscal year ends
- January 3
- Incorporated in
- UT
- Headquarters
- Salt Lake City, UT
- SEC filer status
- Accelerated filer
- SEC CIK
- 896264
- Former names
- USANA INC (until Apr 27, 2000)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.